Prepare for your visit
Michael Ray Falk
Nurse Anesthetist, Certified Registered · Colorado Springs, CO · NPI 1447367438
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$442.33
in general payments reported to CMS, 2019-2025 · $343 in 2025
The $343 reported for 2025 was more than what 95% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Who reported paying
General payments only, top 4 by amount.
- Takeda Pharmaceuticals U.S.A., INC. $181.30
- Qol Medical, LLC $179.62
- Regeneron Healthcare Solutions, INC. $44.95
- Intercept Pharmaceuticals, INC. $36.46
Drugs and devices associated with these payments
Sucraid Eohilia Entyvio Dupixent Ocaliva
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Michael Falk listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11114908/michael-ray-falk